KLK3 and posterior cortical atrophy: Platelet factor 4 variant 1 and cysteine-rich secretory protein 3 when combined could attain better discrimination in gray zone of PSA (4–10 ng/ml) and had the potential to differentiate between high-grade prostatic intraepithelial neoplasia and PCa (80).